AIM ImmunoTech (AIM) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts AIM Hot Sheet
Join SI Premium – FREE
AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($0.03), $0.10 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Therapeutics files for proposed IPO
- Zentek shares to move from Nasdaq to OTC Markets on Sept. 2
- Chagee Holdings (CHA) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
